Bolsa, mercados y cotizaciones

Valeant nears deal to buy Salix for about $10 billion: WSJ

(Reuters) - Valeant Pharmaceuticals International is near a deal to buy Salix Pharmaceuticals Ltd for about $10 billion, the Wall Street Journal reported on Saturday.

(Reporting by Eric Beech)

WhatsAppFacebookFacebookTwitterTwitterLinkedinLinkedinBeloudBeloudBluesky